Broach Lifecare Hospital Ltd vs Kmc Speciality Hospitals India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Broach Lifecare Hospital Ltd is ₹ 14 as of 05 Oct 15:30 . The P/E Ratio of Broach Lifecare Hospital Ltd changed from 18.8 on March 2025 to 124.2 on March 2026 . This represents a CAGR of 157.03% over 2 yearsThe P/E Ratio of KMC Speciality Hospitals (India) Ltd changed from 28 on March 2021 to 27.4 on March 2026 . This represents a CAGR of -0.36% over 6 years The Market Cap of Broach Lifecare Hospital Ltd changed from ₹ 10.04 crore on March 2025 to ₹ 10.56 crore on March 2026 . This represents a CAGR of 2.56% over 2 yearsThe Market Cap of KMC Speciality Hospitals (India) Ltd changed from ₹ 355.56 crore on March 2021 to ₹ 1284 crore on March 2026 . This represents a CAGR of 23.87% over 6 years The revenue of Broach Lifecare Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of KMC Speciality Hospitals (India) Ltd for the Jun '26 is ₹ 93.58 crore as compare to the Mar '26 revenue of ₹ 84.16 crore. This represent the growth of 11.19% The ebitda of Broach Lifecare Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of KMC Speciality Hospitals (India) Ltd for the Jun '26 is ₹ 30.29 crore as compare to the Mar '26 ebitda of ₹ 27.78 crore. This represent the growth of 9.04% The net profit of Broach Lifecare Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of KMC Speciality Hospitals (India) Ltd changed from ₹ 5.51 crore to ₹ 16.57 crore over 9 quarters. This represents a CAGR of 63.12% The Dividend Payout of Broach Lifecare Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of KMC Speciality Hospitals (India) Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Broach Lifecare Hospital Ltd

Broach Lifecare Hospital Limited was incorporated as 'Broach Lifecare Hospital Private Limited' dated April 25, 2023, with the Registrar of Companies, Central Registration Centre.
Further, in accordance with the main objects, the Company acquired the sole proprietorship concerns of Dr. Jaykumar Narendra Vyas, the Promoter comprising of the Hospitals i.e.
Dr. Vyas's Heart Hospital and Dr. Vyas Hospital pursuant to a Business Transfer Agreement date July 17, 2023.
Thereafter, the Company was converted into a public limited Company and the name was changed to Broach Lifecare Hospital Limited' dated November 7, 2023 at ROC, Ahmedabad. The Company operates boutique Hospitals under the brand 'Maple Hospitals' and provides dedicated round-the-clock services to patients with heart ailments consisting of non-invasive cardiology services such as, 2D Echocardiography, Electrocardiography, Tread Mill Test, Holter monitoring, Ambulatory Blood Pressure Measurement, Stress test, Dobutamine Stress Echocardiography in June 2023, the Company ventured into interventional cardiac services such as, coronary angiography and stenting, percutaneous coronary intervention (PCI) and primary PCI for acute myocardial infarction as a division.

About KMC Speciality Hospitals (India) Ltd

KMC Speciality Hospitals (India) Limited was originally incorporated as 'Advanced Medical Care Private Limited' on December 31, 1982 and was converted into a Public Limited Company on July 15, 1988.
The name of the Company was changed to 'Seahorse Hospitals Limited' on March 21, 1995 and to its current name 'KMC Speciality Hospitals (India) Limited' with effect from October 24, 2008. The Company is a part of the KMC Group of Hospitals based at Tiruchirappalli.
The Company is a super speciality hospital based in Trichy, belonging to the Kauvery Hospitals Group.
The Company is primarily engaged in the business of rendering medical and healthcare services.
It provide quality healthcare to patients in key specialty areas such as Neurosurgery, Cardiovascular & thoracic surgery, Orthopedics, Plastic and Reconstructive Surgery, Gynecology, Neonatology and Nephrology (including renal transplants).

FAQs for the comparison of Broach Lifecare Hospital Ltd and KMC Speciality Hospitals (India) Ltd

Which company has a larger market capitalization, Broach Lifecare Hospital Ltd or KMC Speciality Hospitals (India) Ltd?

Market cap of Broach Lifecare Hospital Ltd is 8 Cr while Market cap of KMC Speciality Hospitals (India) Ltd is 2,351 Cr

What are the key factors driving the stock performance of Broach Lifecare Hospital Ltd and KMC Speciality Hospitals (India) Ltd?

The stock performance of Broach Lifecare Hospital Ltd and KMC Speciality Hospitals (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Broach Lifecare Hospital Ltd and KMC Speciality Hospitals (India) Ltd?

As of October 25, 2026, the Broach Lifecare Hospital Ltd stock price is INR ₹14.0. On the other hand, KMC Speciality Hospitals (India) Ltd stock price is INR ₹144.2.

How do dividend payouts of Broach Lifecare Hospital Ltd and KMC Speciality Hospitals (India) Ltd compare?

To compare the dividend payouts of Broach Lifecare Hospital Ltd and KMC Speciality Hospitals (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.